XING SE

  • WKN: XNG888
  • ISIN: DE000XNG8888
  • Land: Deutschland

Nachricht vom 12.01.2018 | 15:14

XING SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

XING SE / Preliminary announcement on the disclosure of financial
statements

12.01.2018 / 15:14
Preliminary announcement of the publication of quarterly reports and
quarterly/interim statements transmitted by DGAP - a service of EQS Group
AG.
The issuer is solely responsible for the content of this announcement.


XING SE hereby announces that the following financial reports shall be disclosed : Report: Quarterly/ Interim statement within the 1st half-year Date of disclosure / German: May 03, 2018 Date of disclosure / English: May 03, 2018 German: https://corporate.xing.com/fileadmin/department/investorrelations/Publikati onen/XING_AG_Ergebnisse_Q1_2018.pdf English: https://corporate.xing.com/fileadmin/department/investorrelations/Publikati onen/XING_AG_results_Q1_2018.pdf Report: Quarterly/ Interim statement within the 2nd half-year Date of disclosure / German: November 07, 2018 Date of disclosure / English: November 07, 2018 German: https://corporate.xing.com/fileadmin/department/investorrelations/Publikati onen/XING_AG_Ergebnisse_Q3_2018.pdf English: https://corporate.xing.com/fileadmin/department/investorrelations/Publikati onen/XING_AG_results_Q3_2018.pdf
12.01.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language: English Company: XING SE Dammtorstraße 30 20354 Hamburg Germany Internet: www.xing.com End of News DGAP News Service

News im Fokus

Commerzbank baut Privatkundenberatung zu ETFs aus

19. Januar 2018, 14:10

Aktuelle Research-Studie

Sanochemia Pharmazeutika AG

Original-Research: Sanochemia Pharmazeutika AG (von Sphene Capital GmbH): Buy

19. Januar 2018